Financhill
Sell
35

FOLD Quote, Financials, Valuation and Earnings

Last price:
$8.89
Seasonality move :
5.08%
Day range:
$8.79 - $9.00
52-week range:
$8.55 - $12.65
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.08x
P/B ratio:
13.95x
Volume:
1.7M
Avg. volume:
2.4M
1-year change:
-25.4%
Market cap:
$2.7B
Revenue:
$528.3M
EPS (TTM):
-$0.18

Amicus Therapeutics SEC Filings

Company Filed Form Type Description
FOLD
Amicus Therapeutics
05/09/2024 10-Q 10-Q filing on 05/09/2024 View Form
FOLD
Amicus Therapeutics
11/08/2023 10-Q 10-Q filing on 11/08/2023 View Form
FOLD
Amicus Therapeutics
08/08/2023 10-Q 10-Q filing on 08/08/2023 View Form
FOLD
Amicus Therapeutics
05/10/2023 10-Q 10-Q filing on 05/10/2023 View Form
FOLD
Amicus Therapeutics
11/07/2022 10-Q 10-Q filing on 11/07/2022 View Form
FOLD
Amicus Therapeutics
08/04/2022 10-Q 10-Q filing on 08/04/2022 View Form
FOLD
Amicus Therapeutics
05/10/2022 10-Q 10-Q filing on 05/10/2022 View Form
FOLD
Amicus Therapeutics
11/09/2021 10-Q 10-Q filing on 11/09/2021 View Form
FOLD
Amicus Therapeutics
08/05/2021 10-Q 10-Q filing on 08/05/2021 View Form
FOLD
Amicus Therapeutics
05/10/2021 10-Q 10-Q filing on 05/10/2021 View Form
FOLD
Amicus Therapeutics
11/05/2020 10-Q 10-Q filing on 11/05/2020 View Form
FOLD
Amicus Therapeutics
08/10/2020 10-Q 10-Q filing on 08/10/2020 View Form
FOLD
Amicus Therapeutics
05/07/2020 10-Q 10-Q filing on 05/07/2020 View Form
FOLD
Amicus Therapeutics
03/02/2020 10-K 10-K filing on 03/02/2020 View Form
FOLD
Amicus Therapeutics
11/12/2019 10-Q 10-Q filing on 11/12/2019 View Form
FOLD
Amicus Therapeutics
08/08/2019 10-Q 10-Q filing on 08/08/2019 View Form
FOLD
Amicus Therapeutics
05/09/2019 10-Q 10-Q filing on 05/09/2019 View Form
FOLD
Amicus Therapeutics
02/28/2019 10-K 10-K filing on 02/28/2019 View Form
FOLD
Amicus Therapeutics
11/05/2018 10-Q 10-Q filing on 11/05/2018 View Form
FOLD
Amicus Therapeutics
08/07/2018 10-Q 10-Q filing on 08/07/2018 View Form
FOLD
Amicus Therapeutics
05/09/2018 10-Q 10-Q filing on 05/09/2018 View Form
FOLD
Amicus Therapeutics
03/01/2018 10-K 10-K filing on 03/01/2018 View Form
FOLD
Amicus Therapeutics
11/08/2017 10-Q 10-Q filing on 11/08/2017 View Form
FOLD
Amicus Therapeutics
08/07/2017 10-Q 10-Q filing on 08/07/2017 View Form
FOLD
Amicus Therapeutics
05/09/2017 10-Q 10-Q filing on 05/09/2017 View Form
FOLD
Amicus Therapeutics
03/03/2017 10-K 10-K filing on 03/03/2017 View Form
FOLD
Amicus Therapeutics
03/01/2017 10-K 10-K filing on 03/01/2017 View Form
FOLD
Amicus Therapeutics
11/07/2016 10-Q 10-Q filing on 11/07/2016 View Form
FOLD
Amicus Therapeutics
08/09/2016 10-Q 10-Q filing on 08/09/2016 View Form
FOLD
Amicus Therapeutics
05/03/2016 10-Q 10-Q filing on 05/03/2016 View Form
FOLD
Amicus Therapeutics
02/29/2016 10-K 10-K filing on 02/29/2016 View Form
FOLD
Amicus Therapeutics
11/04/2015 10-Q 10-Q filing on 11/04/2015 View Form
FOLD
Amicus Therapeutics
08/05/2015 10-Q 10-Q filing on 08/05/2015 View Form
FOLD
Amicus Therapeutics
05/05/2015 10-Q 10-Q filing on 05/05/2015 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Qualcomm Stock: 5G Leader at a Bargain Price?
Qualcomm Stock: 5G Leader at a Bargain Price?

Chip giant QUALCOMM Incorporated (NASDAQ:QCOM) was the ultimate chip company…

What Is Buffett Buying and Selling Now?
What Is Buffett Buying and Selling Now?

In Q4 of last year, Warren Buffett made a few…

3 Safest Stocks to Buy Now
3 Safest Stocks to Buy Now

With the S&P 500 now in correction and stocks selling…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 34x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Sell
47
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Alerts

Sell
5
CABO alert for Mar 14

Cable One [CABO] is down 3.97% over the past day.

Sell
38
ADBE alert for Mar 14

Adobe [ADBE] is up 4.43% over the past day.

Sell
29
CAR alert for Mar 14

Avis Budget Group [CAR] is up 11.68% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock